A Phase 1 Trial Assessing Pharmacokinetics and Safety of CAM2056 (Semaglutide Subcutaneous Depot)
HS-24-787
Phase 1 other active
Quick answer
A Phase 1 Trial Assessing Pharmacokinetics and Safety of CAM2056 (Semaglutide Subcutaneous Depot) for Body weight management is a Phase 1 program (other) at Camurus Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Camurus Pty Ltd
- Indication
- Body weight management
- Phase
- Phase 1
- Modality
- other
- Status
- active